Scotia Capital’s Organon & Co OGN Stock Holding History

Scotia Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,591	Closed	-$314K	–	903
2021 Q3	$314K	Sell	9,591 -5,632	-37%	-$180K	﹤0.01%	708
2021 Q2	$461K	Buy	+15,223	New	+$501K	﹤0.01%	649

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Scotia Capital's OGN Position: Q4 2021 in Review

Scotia Capital sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 9,591 shares — an estimated $314K sold.

Scotia Capital first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $461K in Q2 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

Scotia Capital reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
Scotia Capital sold 9,591 Organon & Co shares in Q4 2021, an estimated $314K.
Scotia Capital first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
Scotia Capital's Organon & Co position peaked at $461K in Q2 2021.
907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Scotia Capital's 13F filing for Q4 2021, filed 11 Feb 2022.